CM Life Sciences III priced its IPO of 48 million units at $10 each. The SPAC offered 8 million more units than initially expected.
Units begin trading today on the Nasdaq under CMLTU. Each consists of one share of Class A common stock and one-fifth of one redeemable warrant, with each whole warrant exercisable at $11.50. After the securities comprising the units begin separate trading, stock and warrants are expected to list under CMLT and CMLTW, respectively.
The offering is expected to close April 9.
CM Life Sciences III is led by by CEO Eli Casdin, founder of Casdin Capital, an investment firm focused on the life sciences and healthcare industry. Read more.
